Impact of immunosuppressive treatment on endothelial biomarkers after kidney transplantation.
D000328:Adult; D015415:Biomarkers / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000628:therapy; D015331:Cohort Studies; D004730:Endothelium, Vascular / Q000187:drug effects*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000379:methods*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D011446:Prospective Studies; D016559:Tacrolimus / Q000008:administration & dosage; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood
D015415:Biomarkers; D007166:Immunosuppressive Agents; D019010:Vascular Cell Adhesion Molecule-1; D009173:Mycophenolic Acid; D016559:Tacrolimus